Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
7th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
acquiree, allergic, Allergy, ASC, autonomy, Biohaven, Bioshin, blood, Boxed, calendar, Champix, closer, Comirnaty, conspired, conventional, criteria, DAC, death, director, donated, DSC, forwarded, frequent, history, Homeland, household, hybrid, Inhibition, Letter, living, nerve, Nurtec, occupational, ODT, onset, package, Paxlovid, placebo, polysaccharide, poorest, preexisting, rescue, rimegepant, ritonavir, routine, scheduled, Sep, sublicense, suffered, Sweden, Switzerland, symptom, tablet, TNF, Trillium, tumor, virtual, zavegepant
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view